TC Biopharm () (TCBP)

AI Score

Unlock

0.50

0.00 (0.00%)

At close: Mar 21, 2025, 3:59 PM

TC Biopharm () Income Statement

Financials in GBP. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	1.43M	1.43M	494.67K	494.67K	494.67K	494.66K	494.67K	494.67K	494.67K	494.66K	494.67K	494.67K
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	1.43M	1.43M	494.67K	494.67K	494.67K	494.66K	494.67K	494.67K	494.67K	494.66K	494.67K	494.67K
Operating Income	-2.05M	-3.44M	-3.28M	-3.28M	-4.88M	-4.18M	-2.08M	-2.08M	-3.96M	-3.96M	-2.33M	-2.16M	-1.4M	-1.4M	-1.61M	-1.52M	-1.88M	-1.88M
Interest Income	n/a	n/a	30.11K	30.11K	90.96K	n/a	381.32K	381.32K	3M	3M	1.92M	1.15M	181.47K	181.47K	68.81K	73.6K	74.31K	74.31K
Pretax Income	-2.09M	-3.43M	-3.32M	-3.32M	-219.97K	-1.03M	-1.41M	-1.41M	-103.67K	-103.67K	-4.52M	-7.3M	-1.58M	-1.58M	-1.68M	-1.44M	-1.75M	-1.75M
Net Income	-1.99M	-3.32M	-3.13M	-3.13M	224.52K	-634.91K	-913.13K	-913.13K	256.33K	256.33K	-3.9M	-7.03M	-1.32M	-1.32M	-1.32M	-1.2M	-1.47M	-1.47M
Selling & General & Admin	1.12M	2.14M	1.63M	1.63M	2.29M	2.23M	1.76M	1.76M	2.61M	2.61M	1.18M	1.05M	442.64K	442.64K	555.55K	475.87K	587.66K	587.67K
Research & Development	939.29K	1.3M	1.85M	1.85M	2.59M	1.93M	1.95M	1.95M	1.85M	1.85M	1.65M	1.6M	1.45M	1.45M	1.57M	1.54M	1.79M	1.79M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	2.05M	3.44M	3.35M	3.35M	129K	1.03M	2.46M	2.46M	2.4M	2.4M	3.09M	6.64M	1.89M	1.89M	2.11M	1.86M	2.17M	2.17M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.92M	1.15M	n/a	n/a	69.22K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	201.16K	201.16K	n/a	n/a	201.16K	201.16K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.05M	3.44M	3.35M	3.35M	129K	1.03M	2.46M	2.46M	2.4M	2.4M	3.09M	6.64M	1.89M	1.89M	2.11M	1.86M	2.17M	2.17M
Income Tax Expense	-105.79K	-110.74K	194.37K	194.37K	444.48K	400K	500K	500K	360K	360K	620.09K	274.94K	256.25K	256.25K	362.54K	241.63K	283.88K	283.88K
Shares Outstanding (Basic)	1.3B	602.77M	186.52M	186.52M	70.72M	41.04M	13.74M	13.74M	13.74M	10M	7.81M	11.22M	11.22M	11.22M	11.22M	11.22M	11.22M	11.22M
Shares Outstanding (Diluted)	1.3B	602.77M	186.52M	186.52M	69.77M	41.04M	13.74M	13.74M	13.74M	10M	7.81M	11.22M	11.22M	11.22M	11.22M	11.22M	11.22M	11.22M
EPS (Basic)	n/a	-0.01	-0.02	-0.02	0.00	-0.02	-0.07	-0.07	n/a	n/a	-0.5	-0.86	n/a	n/a	-0.16	-0.14	n/a	n/a
EPS (Diluted)	n/a	-0.01	-0.02	-0.02	0.00	-0.02	-0.07	-0.07	n/a	n/a	-0.5	-0.86	n/a	n/a	-0.16	-0.14	n/a	n/a
EBITDA	-1.93M	-3.31M	-3.13M	-3.13M	-4.66M	-3.98M	-1.9M	-1.9M	-3.76M	-3.76M	-2.14M	-1.96M	-1.19M	-1.19M	-1.4M	-1.31M	-1.66M	-1.66M
EBIT	-2.05M	-3.44M	n/a	n/a	3.96M	-4.17M	n/a	n/a	n/a	n/a	-2.6M	-6.15M	n/a	n/a	-1.61M	n/a	n/a	n/a
Depreciation & Amortization	120.58K	127.02K	144.28K	144.28K	216.84K	180.97K	182.33K	182.33K	198.9K	198.91K	184.68K	200.17K	213.56K	213.56K	205.84K	218.4K	220.41K	220.41K